TY - JOUR A1 - Kumar, Ashok A1 - Kumar, Priti T1 - Multi-component botanical drugs for degenerative diseases Y1 - 2018/7/1 JF - Clinical Trials in Degenerative Diseases JO - Clin Trials Degener Dis SP - 115 EP - 118 VL - 3 IS - 3 UR - https://www.clinicaltdd.com/article.asp?issn=2542-3975;year=2018;volume=3;issue=3;spage=115;epage=118;aulast=Kumar DO - 10.4103/2542-3975.242960 N2 - Millions of people around the world are suffering from various types of degenerative diseases. Most of these diseases also classified as chronic diseases are of longer duration and slow progression. Most of these disorders are incurable but are manageable with presently available therapies. Chronic degenerative disorders such as heart disease, cancer, asthma, arthritis, diabetes, kidney failure etc. are responsible for over 70% mortality world over. For managing a number of degenerative diseases, single molecule drugs have played a major role. However, issues of unavailability of curative therapeutics, suboptimal response, treatment resistance and adverse drug reactions remain problematic and pose a serious concern. Under such circumstances, botanical drugs can play an important role in changing the health care scenario worldwide. Investigators should focus on development of newer botanical drugs to provide holistic health to masses in safe, economic and effective manner. ER -